Patent details
EP2195026 Title: Anti-sclerostin antibodies
Basic Information
- Publication number:
- EP2195026
- PCT Application Number:
- PCT/US/2008/076679
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP088326905
- PCT Publication Number:
- WO/2009/039175
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Anti-sclerostin antibodies
- French Title of Invention:
- Anticorps anti-sclérostine
- German Title of Invention:
- Anti-Sclerostin-Antikörper
- SPC Number:
Dates
- Filing date:
- 17/09/2008
- Grant date:
- 25/12/2013
- EP Publication Date:
- 25/12/2013
- PCT Publication Date:
- 26/03/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 16/06/2010
- EP B1 Publication Date:
- 25/12/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/09/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 04/04/2014
- Name:
- Amgen Inc
- Address:
- One Amgen Center Drive, Thousand Oaks, California 91320-1799, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 29/01/2014
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- PADHI Ian, Desmond
- Address:
- United States (US)
2
- Name:
- JANG Graham, Richard
- Address:
- United States (US)
Priority
- Priority Number:
- 973024 P
- Priority Date:
- 17/09/2007
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- A61K 39/395;
Annual Fees
- Annual Fee Due Date:
- 30/09/2025
- Annual Fee Number:
- 18
- Annual Fee Amount:
- 262 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 13/09/2024
- Last Annual Fee Paid Number:
- 17
- Last Annual Fee Paid Amount:
- 246 Euro
- Payer:
- CPA GLOBAL THE IP PLATFORM
| Filing date | Document type | Number of pages |
|---|